Very bullish presentation. Demand and sales pipeline so strong they have had to up their forecast for recurring revenue from $50 mill to $60 Million over next 4 years. The demand for automation type products in healthcare is accelerating faster.
There is 30,000 pathology labs in Europe alone that are potential customers they could use Beamtree.
Hong Kong mentioned a few times in relation to Ainsoff. A lot of interest in this product across the world.
In my opinion, this company has serious short, medium and long term upside.
Very bullish presentation. Demand and sales pipeline so strong...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BMT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
-0.005(2.22%) |
Mkt cap ! $63.58M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 22.0¢ | $10.44K | 47.11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 94658 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 6970 | 1 |
View Market Depth
| Last trade - 14.16pm 30/07/2024 (20 minute delay) ? |
| BMT (ASX) Chart |